Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 2 |
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Principal investigators over-optimistically forecast scientific and operational outcomes for clinical trials.
PLoS One. 2022 Feb 8;17(2):e0262862. doi: 10.1371/journal.pone.0262862. eCollection 2022.
PLoS One. 2022.
PMID: 35134071
Free PMC article.
Impact of Precision Medicine on Efficiencies of Novel Drug Development in Cancer.
Sarvas H, Carlisle B, Dolter S, Vinarov E, Kimmelman J.
Sarvas H, et al. Among authors: dolter s.
J Natl Cancer Inst. 2020 Aug 1;112(8):859-862. doi: 10.1093/jnci/djz212.
J Natl Cancer Inst. 2020.
PMID: 31722417
Item in Clipboard
Lung Immune Therapy Evaluation (LITE) Risk, a Novel Prognostic Model for Patients With Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Blockade.
Navani V, Meyers DE, Ruan Y, Boyne DJ, O'Sullivan DE, Dolter S, Grosjean HA, Stukalin I, Heng DYC, Morris DG, Brenner DR, Sangha R, Cheung WY, Pabani A.
Navani V, et al. Among authors: dolter s.
Clin Lung Cancer. 2023 May;24(3):e152-e159. doi: 10.1016/j.cllc.2022.12.014. Epub 2023 Jan 20.
Clin Lung Cancer. 2023.
PMID: 36774234
Free article.
Item in Clipboard
Impact of Performance Status on Survival Outcomes and Health Care Utilization in Patients With Advanced NSCLC Treated With Immune Checkpoint Inhibitors.
Meyers DE, Pasternak M, Dolter S, Grosjean HAI, Lim CA, Stukalin I, Goutam S, Navani V, Heng DYC, Cheung WY, Morris DG, Pabani A.
Meyers DE, et al. Among authors: dolter s.
JTO Clin Res Rep. 2023 Feb 24;4(4):100482. doi: 10.1016/j.jtocrr.2023.100482. eCollection 2023 Apr.
JTO Clin Res Rep. 2023.
PMID: 37090101
Free PMC article.
Item in Clipboard
Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials.
Gan CL, Stukalin I, Meyers DE, Dudani S, Grosjean HAI, Dolter S, Ewanchuk BW, Goutam S, Sander M, Wells C, Pabani A, Cheng T, Monzon J, Morris D, Basappa NS, Pal SK, Wood LA, Donskov F, Choueiri TK, Heng DYC.
Gan CL, et al. Among authors: dolter s.
Eur J Cancer. 2021 Jul;151:115-125. doi: 10.1016/j.ejca.2021.04.004. Epub 2021 May 8.
Eur J Cancer. 2021.
PMID: 33975059
Free article.
Item in Clipboard
Effectiveness and Safety of First-Line Pembrolizumab in Older Adults with PD-L1 Positive Non-Small Cell Lung Cancer: A Retrospective Cohort Study of the Alberta Immunotherapy Database.
Grosjean HAI, Dolter S, Meyers DE, Ding PQ, Stukalin I, Goutam S, Kong S, Chu Q, Heng DYC, Bebb DG, Morris DG, Cheung WY, Pabani A.
Grosjean HAI, et al. Among authors: dolter s.
Curr Oncol. 2021 Oct 18;28(5):4213-4222. doi: 10.3390/curroncol28050357.
Curr Oncol. 2021.
PMID: 34677275
Free PMC article.
Item in Clipboard
Cite
Cite